FLG and Alzheimer disease: The genes of the epidermal barrier and junction (FLG, FLG2, and CLDN8), lipid synthesis and metabolism (FA2H and ELOVL3), and negative immune regulators (IL-34 and IL-37) were downregulated in the lesional skin of patients with AD (19).